MedPath

上海玉瑞生物科技（安阳）药业有限公司

Ownership
-
Established
2005-04-18
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

113

NMPA:113

Drug Approvals

Acetyl Kitasamycin

Product Name
乙酰吉他霉素
Approval Number
国药准字H10960068
Approval Date
Apr 18, 2024
NMPA

Erythromycin Estolate

Product Name
依托红霉素
Approval Number
国药准字H41022968
Approval Date
Apr 18, 2024
NMPA

Antazoline Hydrochloride

Product Name
盐酸安他唑啉
Approval Number
国药准字H41021067
Approval Date
Apr 18, 2024
NMPA

Norfloxacin

Product Name
诺氟沙星
Approval Number
国药准字H41022964
Approval Date
Apr 18, 2024
NMPA

Furazolidone

Product Name
呋喃唑酮
Approval Number
国药准字H41021032
Approval Date
Feb 7, 2024
NMPA

Griseofulvin Tablets

Product Name
灰黄霉素片
Approval Number
国药准字H41020028
Approval Date
Aug 4, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H41020021
Approval Date
Aug 4, 2020
NMPA

Pyritinol Hydrochloride Tablets

Product Name
盐酸吡硫醇片
Approval Number
国药准字H41020671
Approval Date
Jul 20, 2020
NMPA

Chloramphenicol Tablets

Product Name
氯霉素片
Approval Number
国药准字H41020661
Approval Date
Jul 20, 2020
NMPA

Phenylbutazone Tablets

Product Name
保泰松片
Approval Number
国药准字H41024190
Approval Date
Jul 20, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.